SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-296005
Filing Date
2020-11-17
Accepted
2020-11-17 16:10:01
Documents
14
Period of Report
2020-11-16
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d25000d8k.htm   iXBRL 8-K 25491
2 EX-99.1 d25000dex991.htm EX-99.1 12497
3 EX-99.2 d25000dex992.htm EX-99.2 15496
  Complete submission text file 0001193125-20-296005.txt   182952

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA gh-20201116.xsd EX-101.SCH 3070
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE gh-20201116_lab.xml EX-101.LAB 17374
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gh-20201116_pre.xml EX-101.PRE 10955
7 EXTRACTED XBRL INSTANCE DOCUMENT d25000d8k_htm.xml XML 3220
Mailing Address 505 PENOBSCOT DR. REDWOOD CITY CA 94063
Business Address 505 PENOBSCOT DR. REDWOOD CITY CA 94063 855-698-8887
Guardant Health, Inc. (Filer) CIK: 0001576280 (see all company filings)

IRS No.: 454139254 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38683 | Film No.: 201321248
SIC: 8071 Services-Medical Laboratories